Genetic screening methods for the detection of mutations responsible for multiple endocrine neoplasia type 1

Katalin Balogh, A. Patócs, Judit Majnik, K. Rácz, L. Hunyady

Research output: Contribution to journalArticle

34 Citations (Scopus)

Abstract

Identification of mutations, which cause genetic diseases can be difficult when the disease is caused by the mutation of a large gene, which contains multiple exons. Detection of these mutations by DNA sequencing can be made more efficient by using mutation detection methods for pre-screening to identify the affected exon and to screen for the presence of already identified mutations in family members. These screening methods include denaturing gradient gel electrophoresis (DGGE), temperature gradient gel electrophoresis (TGGE), single-strand conformation polymorphism, conformation-sensitive gel electrophoresis (CSGE), heteroduplex analysis and denaturing high-performance liquid chromatography (DHPLC). We discuss the advantages and shortcomings of these methods by reviewing the results of studies screening for mutations causing multiple endocrine neoplasia type 1 (MEN 1) syndrome, an autosomal dominant disorder characterized by endocrine tumours of the anterior pituitary gland, parathyroid glands, and pancreas. MEN 1 is caused by mutations of the MEN1 gene, a tumour suppressor gene, which contains one untranslated exon and nine exons. Previous studies have identified more than 400 germline and somatic mutations spreading across all the encoding sequence, and found no mutational "hot spot" or genotype-phenotype correlation. The wide diversity of mutations in the entire coding region of the MEN1 gene makes mutation screening time-consuming and expensive. We conclude that combination of mutation detection methods with DNA sequencing enhances the efficiency of identifying pathogenic mutations. However, it should be considered that experimental determination of the optimal electrophoresis conditions, such as using perpendicular electrophoresis to optimise DGGE or TGGE, is more useful than computerized algorithms to calculate these parameters.

Original languageEnglish
Pages (from-to)74-81
Number of pages8
JournalMolecular Genetics and Metabolism
Volume83
Issue number1-2
DOIs
Publication statusPublished - Sep 2004

Fingerprint

Multiple Endocrine Neoplasia Type 1
Genetic Testing
Electrophoresis
Screening
Mutation
Gels
Exons
Denaturing Gradient Gel Electrophoresis
Genes
Thermal gradients
Conformations
Tumors
DNA Sequence Analysis
DNA
High performance liquid chromatography
Polymorphism
Heteroduplex Analysis
Multiple Endocrine Neoplasia
Inborn Genetic Diseases
Anterior Pituitary Gland

Keywords

  • CSGE
  • DGGE
  • DHPLC
  • Direct sequencing
  • Genetic screening
  • Multiple endocrine neoplasia type 1
  • Poland
  • SSCP
  • TTGE
  • WinMelt

ASJC Scopus subject areas

  • Biochemistry
  • Genetics
  • Endocrinology, Diabetes and Metabolism

Cite this

Genetic screening methods for the detection of mutations responsible for multiple endocrine neoplasia type 1. / Balogh, Katalin; Patócs, A.; Majnik, Judit; Rácz, K.; Hunyady, L.

In: Molecular Genetics and Metabolism, Vol. 83, No. 1-2, 09.2004, p. 74-81.

Research output: Contribution to journalArticle

@article{55af7e1b60b2469b8ff55365e92f5492,
title = "Genetic screening methods for the detection of mutations responsible for multiple endocrine neoplasia type 1",
abstract = "Identification of mutations, which cause genetic diseases can be difficult when the disease is caused by the mutation of a large gene, which contains multiple exons. Detection of these mutations by DNA sequencing can be made more efficient by using mutation detection methods for pre-screening to identify the affected exon and to screen for the presence of already identified mutations in family members. These screening methods include denaturing gradient gel electrophoresis (DGGE), temperature gradient gel electrophoresis (TGGE), single-strand conformation polymorphism, conformation-sensitive gel electrophoresis (CSGE), heteroduplex analysis and denaturing high-performance liquid chromatography (DHPLC). We discuss the advantages and shortcomings of these methods by reviewing the results of studies screening for mutations causing multiple endocrine neoplasia type 1 (MEN 1) syndrome, an autosomal dominant disorder characterized by endocrine tumours of the anterior pituitary gland, parathyroid glands, and pancreas. MEN 1 is caused by mutations of the MEN1 gene, a tumour suppressor gene, which contains one untranslated exon and nine exons. Previous studies have identified more than 400 germline and somatic mutations spreading across all the encoding sequence, and found no mutational {"}hot spot{"} or genotype-phenotype correlation. The wide diversity of mutations in the entire coding region of the MEN1 gene makes mutation screening time-consuming and expensive. We conclude that combination of mutation detection methods with DNA sequencing enhances the efficiency of identifying pathogenic mutations. However, it should be considered that experimental determination of the optimal electrophoresis conditions, such as using perpendicular electrophoresis to optimise DGGE or TGGE, is more useful than computerized algorithms to calculate these parameters.",
keywords = "CSGE, DGGE, DHPLC, Direct sequencing, Genetic screening, Multiple endocrine neoplasia type 1, Poland, SSCP, TTGE, WinMelt",
author = "Katalin Balogh and A. Pat{\'o}cs and Judit Majnik and K. R{\'a}cz and L. Hunyady",
year = "2004",
month = "9",
doi = "10.1016/j.ymgme.2004.08.013",
language = "English",
volume = "83",
pages = "74--81",
journal = "Molecular Genetics and Metabolism",
issn = "1096-7192",
publisher = "Academic Press Inc.",
number = "1-2",

}

TY - JOUR

T1 - Genetic screening methods for the detection of mutations responsible for multiple endocrine neoplasia type 1

AU - Balogh, Katalin

AU - Patócs, A.

AU - Majnik, Judit

AU - Rácz, K.

AU - Hunyady, L.

PY - 2004/9

Y1 - 2004/9

N2 - Identification of mutations, which cause genetic diseases can be difficult when the disease is caused by the mutation of a large gene, which contains multiple exons. Detection of these mutations by DNA sequencing can be made more efficient by using mutation detection methods for pre-screening to identify the affected exon and to screen for the presence of already identified mutations in family members. These screening methods include denaturing gradient gel electrophoresis (DGGE), temperature gradient gel electrophoresis (TGGE), single-strand conformation polymorphism, conformation-sensitive gel electrophoresis (CSGE), heteroduplex analysis and denaturing high-performance liquid chromatography (DHPLC). We discuss the advantages and shortcomings of these methods by reviewing the results of studies screening for mutations causing multiple endocrine neoplasia type 1 (MEN 1) syndrome, an autosomal dominant disorder characterized by endocrine tumours of the anterior pituitary gland, parathyroid glands, and pancreas. MEN 1 is caused by mutations of the MEN1 gene, a tumour suppressor gene, which contains one untranslated exon and nine exons. Previous studies have identified more than 400 germline and somatic mutations spreading across all the encoding sequence, and found no mutational "hot spot" or genotype-phenotype correlation. The wide diversity of mutations in the entire coding region of the MEN1 gene makes mutation screening time-consuming and expensive. We conclude that combination of mutation detection methods with DNA sequencing enhances the efficiency of identifying pathogenic mutations. However, it should be considered that experimental determination of the optimal electrophoresis conditions, such as using perpendicular electrophoresis to optimise DGGE or TGGE, is more useful than computerized algorithms to calculate these parameters.

AB - Identification of mutations, which cause genetic diseases can be difficult when the disease is caused by the mutation of a large gene, which contains multiple exons. Detection of these mutations by DNA sequencing can be made more efficient by using mutation detection methods for pre-screening to identify the affected exon and to screen for the presence of already identified mutations in family members. These screening methods include denaturing gradient gel electrophoresis (DGGE), temperature gradient gel electrophoresis (TGGE), single-strand conformation polymorphism, conformation-sensitive gel electrophoresis (CSGE), heteroduplex analysis and denaturing high-performance liquid chromatography (DHPLC). We discuss the advantages and shortcomings of these methods by reviewing the results of studies screening for mutations causing multiple endocrine neoplasia type 1 (MEN 1) syndrome, an autosomal dominant disorder characterized by endocrine tumours of the anterior pituitary gland, parathyroid glands, and pancreas. MEN 1 is caused by mutations of the MEN1 gene, a tumour suppressor gene, which contains one untranslated exon and nine exons. Previous studies have identified more than 400 germline and somatic mutations spreading across all the encoding sequence, and found no mutational "hot spot" or genotype-phenotype correlation. The wide diversity of mutations in the entire coding region of the MEN1 gene makes mutation screening time-consuming and expensive. We conclude that combination of mutation detection methods with DNA sequencing enhances the efficiency of identifying pathogenic mutations. However, it should be considered that experimental determination of the optimal electrophoresis conditions, such as using perpendicular electrophoresis to optimise DGGE or TGGE, is more useful than computerized algorithms to calculate these parameters.

KW - CSGE

KW - DGGE

KW - DHPLC

KW - Direct sequencing

KW - Genetic screening

KW - Multiple endocrine neoplasia type 1

KW - Poland

KW - SSCP

KW - TTGE

KW - WinMelt

UR - http://www.scopus.com/inward/record.url?scp=4744346566&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=4744346566&partnerID=8YFLogxK

U2 - 10.1016/j.ymgme.2004.08.013

DO - 10.1016/j.ymgme.2004.08.013

M3 - Article

VL - 83

SP - 74

EP - 81

JO - Molecular Genetics and Metabolism

JF - Molecular Genetics and Metabolism

SN - 1096-7192

IS - 1-2

ER -